Key facts
- Panda Surgical’s last known valuation is $2.5M (May 2023).
- It has raised $2.5M; the latest was Early Stage VC ($1.3M) in Sep 2025.
- Notable investors include New Wave Ventures, NVIDIA Inception, National Institute for Health Research Invention for Innovation, National Institute for Health and Care Research, Oxford Investment Consultants — 7 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 7 names
- ·Watchlist + deal alerts for Panda Surgical
- ·The full record, as it builds
Funding rounds
No funding rounds for Panda Surgical are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About Panda Surgical
Developer of robotics neurosurgery systems designed to increase the efficacy and safety of minimally invasive neurosurgery. The company designs and develops handheld robotic and AI-based systems and platforms that incorporate exchangeable wristed surgical tools, enabling doctors to perform various minimally invasive neurosurgery to remove tumors and abnormalities deep within the brain and spine.
- Sector
- Information Technology
- HQ
- London, United Kingdom
- Founded
- 2022
- Employees
- 7
- Website
- panda-surgical.com/
- Ownership
- Privately Held (backing)
Panda Surgical doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in Panda Surgical shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on Panda Surgical in its N-PORT filings yet. We sweep new filings monthly.